Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aveo Pharmaceuticals (NQ: AVEO ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 19, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 14.99 (49) Ask (Size) 15.00 (111) Prev. Close 15.00 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding 34,373,995 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee March 28, 2024 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee March 25, 2024 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire Performance More News Read More AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist February 06, 2024 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout October 18, 2022 Via Investor's Business Daily AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) January 16, 2024 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire LG Chem Completes Acquisition of AVEO Oncology January 19, 2023 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire AVEO Oncology Stockholders Approve Acquisition by LG Chem January 05, 2023 From AVEO Pharmaceuticals, Inc. Via GlobeNewswire Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report? November 11, 2022 Via MarketBeat Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 November 08, 2022 Via Benzinga BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Altra Industrial Motion Corp. (Nasdaq - AIMC), UserTesting, Inc. (NYSE - USER), AVEO Pharmaceuticals, Inc. (Nasdaq - AVEO), Limestone Bancorp, Inc. (Nasdaq - LMST) October 31, 2022 From Brodsky & Smith LLC Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022 October 24, 2022 Via Benzinga US Stock Futures Lower Following Friday's Rally; Tesla In Focus October 24, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022 October 19, 2022 Via Benzinga Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday October 19, 2022 Via Benzinga Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday October 19, 2022 Via Benzinga AVEO ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AVEO Oncology - AVEO October 18, 2022 From Kahn Swick & Foti, LLC Via Business Wire Crude Oil Drops Over 2%; Akouos Shares Spike Higher October 18, 2022 Via Benzinga Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views October 18, 2022 Via Benzinga Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session October 18, 2022 Via Benzinga Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote October 18, 2022 Via InvestorPlace Looking Into AVEO Pharmaceuticals's Recent Short Interest October 18, 2022 Via Benzinga Why Is Ra Medical (RMED) Stock Up 25% Today? October 18, 2022 Via InvestorPlace US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points October 18, 2022 Via Benzinga What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today? October 18, 2022 Via InvestorPlace Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18 October 18, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.